Robert J. Lefkowitz Md serves as Executive at LEXICON PHARMACEUTICALS, INC./DE, where they oversee executive responsibilities. Since joining the company, Robert J. Lefkowitz Md has executed 12 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Apr 28, 2024 involved exercising options for 8,032 shares valued at $0.
Robert J. Lefkowitz Md currently holds 48,364 shares of LEXICON PHARMACEUTICALS, INC./DE (LXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Robert J. Lefkowitz Md has been a net neutral trader of LXRX stock. They have purchased $0 and sold $0 worth of shares.
Robert J. Lefkowitz Md's most recent insider trade was on Apr 28, 2024, when they sold 8,032 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 9,302 |
| $N/A |
| Discretionary |
| Apr 30, 2022 | LXRX | $0 | Option Exercise | 4,024 | $N/A | Discretionary |
| Apr 24, 2021 | LXRX | $0 | Option Exercise | 10,638 | $N/A | Discretionary |
| Apr 26, 2020 | LXRX | $0 | Option Exercise | 3,466 | $N/A | Discretionary |
| Apr 27, 2018 | LXRX | $0 | Award | 2,564 | $N/A | Discretionary |
| Apr 28, 2017 | LXRX | $0 | Award | 1,281 | $N/A | Discretionary |
| Apr 29, 2016 | LXRX | $0 | Award | 1,432 | $N/A | Discretionary |
| Apr 24, 2015 | LXRX | $0 | Award | 18,691 | $N/A | Discretionary |
| Apr 25, 2014 | LXRX | $0 | Award | 12,820 | $N/A | Discretionary |
| May 10, 2013 | LXRX | $0 | Award | 10,101 | $N/A | Discretionary |
| Apr 27, 2012 | LXRX | $0 | Award | 11,764 | $N/A | Discretionary |